Clinical Trials Logo
  1. Home
  2. Peripheral Arterial Disease
  3. NCT06252181
  4. Details
NCT06252181 Clinical Trial

Pain and Hemodynamics in Peripheral Arterial Disease: Response to Pulsed Electromagnetic Treatment

Peripheral Arterial Disease Clinical Trial

Official title:
Pain and Hemodynamics in Peripheral Arterial Disease: Response to Pulsed Electromagnetic Treatment in Elderly

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06252181
Other study ID # P.T.REC/012/004285
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 15, 2022
Est. completion date March 10, 2024

Study information
Verified date February 2024
Source Ahram Canadian University
Contact hagar El-Hadidy, lecturer
Phone 01007453552
Email hagarhadidy2016@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

patients with peripheral arterial disease are recommended to perform all exercise forms including elliptical type. electromagnetic treatment addition to exercise may increase benefits of this exercise

Description:

patients (40 elderly) with peripheral arterial disease who take their medications will be divided to older patients group that receive one hour elliptical exercise (n=20 patients, exercise will be applied 3 times per the week for eight week) and a group (n=20) that receive 3 sessions per weeks of 8-week electromagnetic one-hour therapy and one hour elliptical exercise (exercise will be applied 3 times per the week for eight week)

Recruitment information / eligibility
Status Recruiting
Enrollment 40
Est. completion date March 10, 2024
Est. primary completion date March 10, 2024
Accepts healthy volunteers No
Gender Male
Age group 65 Years to 75 Years
Eligibility Inclusion Criteria: - older patients - peripheral arterial disease patients Exclusion Criteria: - cardiac elders - respiratory elders - renal elders

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• electromagnetic pulsed therapy
patients (20 elderly) with peripheral arterial disease who take their medications will receive one hour elliptical exercise ( exercise will be applied 3 times per the week for eight week) and 3 sessions per weeks of 8-week electromagnetic one-hour pulsed therapy
• elliptical exercise
patients (20 elderly) with peripheral arterial disease who take their medications will receive one hour elliptical exercise (n=20 patients, exercise will be applied 3 times per the week for eight week)

Locations
Country Name City State
Egypt Ahram canadian university Giza

Sponsors (1)
Lead Sponsor Collaborator
Ahram Canadian University

Country where clinical trial is conducted

Egypt, 

Outcome
Type Measure Description Time frame Safety issue
Primary ankle brachial index it is an vascular index used in assessment of peripheral arterial disease progression It will be measured after 8 weeks
Secondary posterior tibial artery diameter increase in vascular diameter of vessel denotes improved arterial disease It will be measured after 8 weeks
Secondary claudication pain time the starting onset time of pain appearance during treadmill test It will be measured after 8 weeks
Secondary claudication pain distance the distance at which onset of pain appeared during treadmill test It will be measured after 8 weeks
Secondary Modified walking impairment questionnaire it assess degree of walking impairment in vascular disease patients It will be measured after 8 weeks
Secondary six minute walking test (pain free distance) pain free distance walked during six minute walking test will be calculated It will be measured after 8 weeks
Secondary six minute walking test (total walked distance) total distance walked during six minute walking test will be calculated it will be measured after 8 weeks
Secondary intermittent claudication questionnaire it will assess health-related quality of life concerning the issue of intermittent claudication it will be measured after 8 weeks
Secondary short form 36 health questionnaire it will assess general quality of life in the patients it will be measured after 8 weeks
Secondary Short physical performance battery total score or points will be assessed from this physical performance test it will be measured after 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06032065 - Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for PAD (SMART PAD) Phase 3
Active, not recruiting NCT03987061 - MOTIV Bioresorbable Scaffold in BTK Artery Disease N/A
Recruiting NCT03506633 - Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients N/A
Active, not recruiting NCT03506646 - Dietary Nitrate Supplementation and Thermoregulation N/A
Active, not recruiting NCT04677725 - NEtwork to Control ATherothrombosis (NEAT Registry)
Recruiting NCT05961943 - RESPONSE-2-PAD to Reduce Sedentary Time in Peripheral Arterial Disease Patients N/A
Recruiting NCT06047002 - Personalised Antiplatelet Therapy for Patients With Symptomatic Peripheral Arterial Disease
Completed NCT03185052 - Feasibility of Outpatient Care After Manual Compression in Patients Treated for Peripheral Arterial Disease by Endovascular Technique With 5F Sheath Femoral Approach N/A
Recruiting NCT05992896 - A Study of Loco-Regional Liposomal Bupivacaine Injection Phase 4
Completed NCT04635501 - AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial N/A
Recruiting NCT04584632 - The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery N/A
Withdrawn NCT03994185 - The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease N/A
Withdrawn NCT03538392 - Serranator® Alto Post Market Clinical Follow Up (PMCF) Study
Recruiting NCT02915796 - Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty Phase 1
Active, not recruiting NCT02900924 - Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D
Completed NCT02901847 - To Evaluate the Introduction of a Public Health Approach to Peripheral Arterial Disease (PAD) Using National Centre for Sport and Exercise Medicine Facilities. N/A
Not yet recruiting NCT02387450 - Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication Phase 2/Phase 3
Not yet recruiting NCT02455726 - Magnesium Oral Supplementation to Reduce Pain Inpatients With Severe Peripheral Arterial Occlusive Disease N/A
Withdrawn NCT02126540 - Trial of Pantheris System, an Atherectomy Device That Provides Imaging While Removing Plaque in Lower Extremity Arteries N/A
Completed NCT02022423 - Physical Activity Daily - An Internet-Based Walking Program for Patients With Peripheral Arterial Disease N/A